Home » Migenix Licenses GenomeQuest's Sequence Searcher

Migenix Licenses GenomeQuest's Sequence Searcher

Apr 17, 2007
NEW YORK (GenomeWeb News) — GenomeQuest said today it is licensing its sequence search technology to Migenix, a Vancouver, BC-based drug developer. 
 
The company, formerly known as Gene-IT, said Migenix will use its GenomeQuest product in its clinical programs, which include drug candidates for hepatitis C, catheter-related infections, and dermatological diseases.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Jun
28
Featured Webinar

An Optimized NGS Workflow for Human Metagenomic Analysis

Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.

What's Popular?

In Clinical Sequencing

  1. Roche to Acquire Outstanding Shares of Foundation Medicine for $2.4B

  2. Mayo Team Describes Clinical RNA Sequencing Assay for Oncogenic Fusions

    Premium

  3. Evidence Builds for Cell-Free DNA Testing to Diagnose Infection in Transplant Patients

    Premium

  4. Natera, Institut Jules Bordet Ink Breast Cancer Research Collaboration

  5. Exome Sequencing Helps Diagnose Primary Antibody Deficiency Patients

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.